Search results
IBD Stock Of The Day Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views
Investor's Business Daily· 1 day agoEli Lilly is Tuesday's IBD Stock Of The Day. Shares are rounding the corner to a breakout after...
Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
Zacks via Yahoo Finance· 1 day agoEli Lilly (LLY) beats first-quarter estimates for earnings but misses the same for sales. It raises...
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
KSAN - KLST San Angelo· 1 day agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...
How Lilly is using its Mounjaro millions to position as biotechs’ ‘partner of choice’
FierceBiotech· 12 hours agoEli Lilly’s explosion into the weight loss space is proving fruitful for shareholders, but it’s also...
Eli Lilly shares target raised by BMO Capital on recent earnings miss By Investing.com
Investing.com· 1 day agoOn Tuesday, BMO Capital Markets adjusted its outlook on Eli Lilly and Company (NYSE:LLY), raising...
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
San Francisco Chronicle· 1 day agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...
Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 20 hours agoOpportunities: Expansion in emerging markets and potential for new product launches. Threats: Patent...
Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views
Investor's Business Daily· 1 day agoIn the March quarter, Zepbound brought in $517.4 million in sales, beating forecasts for $373...
Eli Lilly and Co (LLY) Q1 2024 Earnings Call Transcript Highlights: Stellar Growth and ...
GuruFocus.com via Yahoo Finance· 18 hours agoDiscover how Eli Lilly and Co (LLY) achieved impressive Q1 results and raised its 2024 outlook, driven by strong product performance and strategic expansions.
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
NBC Bay Area· 2 days agoEli Lilly reported first-quarter adjusted profit that topped Wall Street's expectations. The company also hiked its full-year guidance on strong sales of ...